Product Offerings

Utilizing extensive R&D capacity and world-class
research relationships to explore and develop
advanced cannabinoid formulations and delivery

Product Pipeline

Evidence-based and indication specific pharmaceutical products designated for FDA and Health Canada approved drug identification numbers (DIN’s).

Primary focus on 6 therapeutic areas:


Current Pipeline in Various Stages of Pre-Clinical and Clinical Development

  • Arthritis
  • Atopic Dermatitis
  • Chronic Pain
  • Epidermolysis Bullosa
  • Neuropathic Pain
  • Palliative Care

In partnership with world class academic

and clinical institutions across

Canada, Colombia and Jamaica